New York Life Investment Management LLC Regenxbio Inc. Transaction History

New York Life Investment Management LLC

  • $9.34 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024
SELL
$12.89 - $20.82 $5,465 - $8,827
-424 Reduced 2.25%
18,404 $330,000
Q3 2023

Nov 07, 2023
SELL
$16.46 - $19.99 $48,836 - $59,310
-2,967 Reduced 13.61%
18,828 $309,000
Q2 2023

Aug 04, 2023
SELL
$17.23 - $21.71 $54,016 - $68,060
-3,135 Reduced 12.58%
21,795 $435,000
Q1 2023

May 08, 2023
BUY
$18.08 - $24.55 $450,734 - $612,031
24,930 New
24,930 $471,000

Others Institutions Holding RGNX

# of Institutions
193
Shares Held
43.5M
Call Options Held
58.9K
Put Options Held
58.4K
View Full List

About REGENXBIO Inc.

RGNX Quotes by TradingView
  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $404M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track New York Life Investment Management LLC Portfolio

Follow New York Life Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York Life Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on New York Life Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email